FCCC LOGO Faculty Publications
Michalski JM , Lawton C , El Naqa I , Ritter M , O'Meara E , Seider MJ , Lee WR , Rosenthal SA , Pisansky T , Catton C , Valicenti RK , Zietman AL , Bosch WR , Sandler H , Buyyounouski MK , Menard C
Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radation therapy for prostate cancer
International Journal of Radiation Oncology Biology Physics. 2010 Feb;76(2) :361-368
PMID: ISI:000274121500008    PMCID: PMC2847420   
Back to previous list
Abstract
Purpose: To define a prostate fossa clinical target volume (PF-CTV) for Radiation Therapy Oncology Group (RTOG) trials using postoperative radiotherapy for prostate cancer. Methods and Materials: An RTOG-sponsored meeting was held to define an appropriate PF-CTV after radical prostatectomy. Data were presented describing radiographic failure patterns after surgery. Target volumes used in previous trials were reviewed. Using contours independently submitted by 13 radiation oncologists, a statistical imputation method derived a preliminary "consensus" PF-CTV. Results: Starting from the model-derived CTV, consensus was reached for a CT image-based PF-CTV. The PF-CTV should extend superiorly from the level of the caudal vas deferens remnant to >8-12 nun interior to vesicourethral anastomosis (VUA). Below the superior border of the pubic symphysis, the anterior border extends to the posterior aspect of the pubis and posteriorly to the rectum, where it may be concave at the level of the VUA. At this level, the lateral border extends to the levator ani. Above the pubic symphysis, the anterior border should encompass the posterior 1-2 cm of the bladder wall; posteriorly, it is bounded by the mesorectal fascia. At this level, the lateral border is the sacrorectogenitopubic fascia. Seminal vesicle remnants, if present, should be included in the CTV if there is pathologic evidence of their involvement. Conclusions: Consensus on postoperative PF-CTV for RT after prostatectomy was reached and is available as a CT image atlas on the RTOG website. This will allow uniformity in defining PF-CTV for clinical trials that include postprostatectomy RT. (C) 2010 Elsevier Inc.
Notes
Michalski, Jeff M. Lawton, Colleen El Naqa, Issam Ritter, Mark O'Meara, Elizabeth Seider, Michael J. Lee, W. Robert Rosenthal, Seth A. Pisansky, Thomas Catton, Charles Valicenti, Richard K. Zietman, Anthony L. Bosch, Walter R. Sandler, Howard Buyyounouski, Mark K. Menard, Cynthia 19 Elsevier science inc; 360 park ave south, new york, ny 10010-1710 usa 550im